EQT has sold Spain-based Igenomix – a reproductive medicine and rare diseases diagnostics business – to listed Swedish market peer Vitrolife in a €1.25bn trade sale that will see EQT acquire a minority stake in Vitrolife.
Calucem reports a turnover of EUR 58m, with an EBITDA of EUR 16m
Should Apex make a firm offer, Cinven would have to significantly up its own bid for the fund administrator
Third exit announced by Lonsdale this year, and the second from its 2016 fund
Paris-based private equity firm is exploring options around a dual-track process